↓ Skip to main content

The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer

Overview of attention for article published in Frontiers in oncology, February 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

twitter
23 X users
wikipedia
1 Wikipedia page

Citations

dimensions_citation
77 Dimensions

Readers on

mendeley
75 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer
Published in
Frontiers in oncology, February 2022
DOI 10.3389/fonc.2022.858462
Pubmed ID
Authors

Nidhi Jyotsana, Kenny T. Ta, Kathleen E. DelGiorno

X Demographics

X Demographics

The data shown below were collected from the profiles of 23 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 75 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 75 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 13%
Student > Ph. D. Student 8 11%
Student > Master 6 8%
Other 6 8%
Professor > Associate Professor 4 5%
Other 6 8%
Unknown 35 47%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 14 19%
Agricultural and Biological Sciences 7 9%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Chemistry 3 4%
Neuroscience 3 4%
Other 8 11%
Unknown 37 49%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 January 2024.
All research outputs
#2,487,727
of 25,775,807 outputs
Outputs from Frontiers in oncology
#574
of 22,796 outputs
Outputs of similar age
#58,666
of 454,348 outputs
Outputs of similar age from Frontiers in oncology
#39
of 1,570 outputs
Altmetric has tracked 25,775,807 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,796 research outputs from this source. They receive a mean Attention Score of 2.9. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 454,348 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 1,570 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.